ArticleJournal of translational medicine2026
The PI3K-AKT pathway mediates the imbalance of bone marrow macrophage polarization in patients with immune thrombocytopenia.
Article in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundImmune thrombocytopenia (ITP), characterized by accelerated destruction and insufficient production of platelets, is commonly thought to be an immune-mediated disorder. The unsatisfactory treatment outcomes associated with the disorder indicate that the pathogenic mechanism underlying ITP requires further investigation. M1 macrophages (MФs) have inhibitory effects on haematopoietic stem cells (HSCs) and megakaryocytes (MKs), whereas M2 MФs have opposite effects. However, whether aberrant MΦ polarization in bone marrow (BM) is involved in the occurrence of ITP remains elusive.
methodsCRISPR/Cas9 technology was used to construct BM MФ-specific PI3K-knockout mice, and RNA sequencing (RNA-seq) was performed on the sorted MKs. The functions of BM MKs were evaluated by apoptosis, platelet production, and the percentage of MK ploidy. M1/M2 MΦ polarization; the PI3K–AKT pathway in MΦs; the phagocytosis, migration, HSC-supporting and MK-supporting abilities of BM MΦs were evaluated. The cytokines in the BM plasma or culture supernatant were detected by ELISA.
resultsCompared with control mice, BM MФ-specific PI3K-knockout mice manifested an abnormal M1/M2 ratio and a sharp decrease in megakaryopoiesis and platelet production. RNA-seq indicated that the activity levels of the platelet activation pathway and its initiator (vWF-GPIb) were decreased in the MKs of the PI3K-knockout mice. The results were subsequently validated in clinical cohorts. Compared with those in healthy controls (HCs), impaired megakaryopoiesis and increased BM M1/M2 ratio with decreased levels of p-PI3K and p-AKT in MФs were observed in patients with ITP. Moreover, dysfunctional BM-MФs from patients with ITP could be restored by TPO in vitro. Mechanistically, vascular endothelial growth factor (VEGF) seemed to be the pivotal mediator in the crosstalk whereby MФs influenced MK maturation by increasing vWF secretion.
conclusionsOur findings revealed that increased BM M1/M2 MФ ratio with downregulation of the PI3K–AKT pathway is associated with impaired haematopoiesis, which may be related to the occurrence of ITP. Moreover, we found that TPO improved the functions of BM MФs from patients with ITP by restoring MФ polarization in vitro, which may partially explain why patients with ITP respond better to corticosteroid combined with TPO therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.